相关实验视频

Updated: Jun 27, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

在CAR-T疗法中使用mRNA脂质纳米颗粒:一种提高疗效的新策略

Zengkai Zhao¹, Mingmei Li¹, Xiang Zheng¹

¹State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Biomedical Materials, Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, People's Republic of China.

|May 16, 2025

概括

脂质纳米粒子 (LNP) 技术通过提高效率和安全性来增强仿真抗原受体T细胞 (CAR-T) 疗法. 简单的LNP为CAR-T细胞生产提供了可扩展,具有成本效益的方法,为先进的免疫疗法铺平了道路.

科学领域:

生物技术是生物技术.
免疫治疗是一种免疫疗法.
基因传递基因传递

背景情况:

化学抗原受体T细胞 (CAR-T) 免疫疗法对血液性恶性瘤有希望,但面临制造复杂性,高成本和安全问题.
目前的CAR-T疗法开发受到这些挑战的阻碍,限制了更广泛的临床应用.

研究的目的:

在CAR-T疗法中提供脂质纳米粒子 (LNP) 应用的全面审查.
突出LNP技术如何解决CAR-T疗法开发和生产中的现有挑战.

主要方法:

关于CAR-T疗法和LNP技术的当前文献的综述.
分析LNP特征和优势作为CAR-T应用的基因传递载体.
关于LNP介导的CAR-T细胞增强,局部编程和组合免疫疗法的研究总结.

主要成果:

在CAR-T治疗中,LNP提供了高效率,低免疫性和增强的安全性.
在活体中通过LNP介导的CAR-T细胞的产生简化了过程,降低了成本,并最大限度地降低了插入性突变发生等风险.
LNP促进体外T细胞转移,局部T细胞编程,T细胞激活和缓解CAR-T的副作用.

结论:

在CAR-T疗法中,LNP技术为CAR-T疗法带来了重大进步,提高了疗效,安全性和成本效益.
此外,LNP有望加速新型CAR-T免疫疗法的开发,包括基于mRNA的输送系统.
该审查强调了LNP的潜力,即彻底改变CAR-T细胞的生产和应用,从而导致更容易获得和更安全的癌症治疗.

关键词:

在CART-T中,我们可以使用CAR-T.免疫疗法免疫疗法脂质纳米颗粒的使用方法提供mRNA的交付.

更多相关视频

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

相关概念视频

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...